2024
Comparative analysis of treatment options for chronic heart failure and depression: a systematic review and Bayesian network meta-analysis
Soleimani H, Nasrollahizadeh A, Hajiqasemi M, Ebrahimzade M, Taheri H, Ebrahimi P, Ashraf H, Samsky M, Hosseini K. Comparative analysis of treatment options for chronic heart failure and depression: a systematic review and Bayesian network meta-analysis. Heart Failure Reviews 2024, 29: 841-852. PMID: 38613598, DOI: 10.1007/s10741-024-10403-z.Peer-Reviewed Original ResearchCognitive behavioral therapyDepression scoresMeasures of depressionTreatment of depressionRandomized controlled trialsHeart failureStandardized mean differenceBehavioral therapyTreatment optionsAnalysis of treatment optionsDepressionEfficacious treatmentMeta-analysisBayesian network meta-analysisChronic heart failureHeart failure patientsNetwork meta-analysisFailure patientsPrimary outcomeWeb of Science databasesControlled trialsMean differencePatientsScoresSystematic review
2023
Prognostic Impact of Repeated NT-proBNP Measurements in Patients With Heart Failure With Reduced Ejection Fraction
Fuery M, Leifer E, Samsky M, Sen S, O'Connor C, Fiuzat M, Ezekowitz J, Piña I, Whellan D, Mark D, Felker G, Desai N, Januzzi J, Ahmad T. Prognostic Impact of Repeated NT-proBNP Measurements in Patients With Heart Failure With Reduced Ejection Fraction. JACC Heart Failure 2023, 12: 479-487. PMID: 38127049, DOI: 10.1016/j.jchf.2023.11.007.Peer-Reviewed Original ResearchNT-proBNP measurementsPrimary trial endpointChronic heart failureNT-proBNP levelsReduced ejection fractionTrial endpointsHeart failureEjection fractionN-terminal pro-B-type natriuretic peptide (NT-proBNP) measurementBaseline NT-proBNP levelsChronic heart failure patientsNT-proBNP monitoringSecondary trial endpointsHeart failure hospitalizationNatriuretic peptide measurementHeart failure patientsCardiovascular deathFailure hospitalizationNT-proBNPFailure patientsPrognostic impactClinical outcomesPrognostic valueOutpatient sitesClinical studies